Reach Us +441414719275
Antibody-directed Cellularization Of Heart Valve Implants | 9628
ISSN: 2157-7552

Journal of Tissue Science & Engineering
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Antibody-directed cellularization of heart valve implants

2nd International Conference on Tissue Science & Regenerative Medicine

J. Koudy Williams

Symposium: J Tissue Sci Eng

DOI: 10.4172/2157-7552.S1.010

O ur goal is to develop and test a bioengineered heart valve for pre-clinical testing and eventualtranslation into clinical use. Initial efforts were to develop heart valve implants pre-seeded with autologous endothelial cells and then conditioned in a bioreactor prior to insertion. Simultaneously, we developed a column (containing speharose beads conjugated with CD133mAb that could collect endothelial precursor cells (EPCs) efficiently from the blood stream when placed as anarterio-venous shunt. Using this same basic approach Dr. Williams assumed and conjugated CDE133mAb on to heart valve scaffolds - process that took 2 hours - and implanted them in the pulmonary position of sheep. The result showed that antibody conjugation accelerated receullularization and structural maturation of the implants and provided preliminary data that these valves may remodel and grow with the patient
J. Koudy Williams is currently a Professor at the Wake Forest Institute for Regenerative Medicine (WFIRM). He spent his first 17 years at Wake Forest in The Department of Pathology/Section on Comparative Medicine exploring the effects of oral contraceptives and hormone replacement therapy on coronary heart disease risk in the coronary arteries of atherosclerotic monkeys. Eight years ago, he joined WFIRM and has since focused his research on regenerative medicine approaches for organ repair and replacement